The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India's indigenously developed coronavirus vaccine, Covaxin, Assam Health Minister Himanta Biswa Sarma said.
He said the GMCH would provide all-out support for the second phase clinical testing of Covaxin, which has already shown successful results in phase-one clinical trials.
According to the Minister, till yesterday night, Assam has tested more than 18.22 lakh samples with 79,667 people testing positive for Covid-19. Of the total cases, 56,734 people have recovered from the disease with the recovery rate being 71.2 per cent and mortality rate 0.25 per cent.
Sarma said 197 people have died due to Covid-19 in the state so far. In terms of recovery rate, he said, five states — Delhi, Tamil Nadu, Gujarat, West Bengal and Tripura — were better than Assam..
Pakistan's Defence Minister Khawaja Asif has exposed the misinformation campaign being run in Pakistan after…
Following India's precision strikes on terrorist sites in Pakistan and Pakistan-occupied Jammu and Kashmir (PoJK)…
The Indian Army have proportionately responded to the unprovoked small-arms and artillery guns firing by…
In a key diplomatic development aimed at bolstering strategic ties, Iran's Foreign Minister Seyed Abbas…
Defence Minister Rajnath Singh said on Wednesday that the Indian Armed Forces displayed their valour…
Soon after the focused strikes on terrorists and terrorist infrastructure at nine sites in Pakistan…
